{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atacand&page=2", "query": { "intervention": "Atacand", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atacand&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-11T09:42:36.272Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01938664", "title": "A Pilot Study of Candesartan as a Treatment for Cocaine Dependence", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine Dependence" ], "interventions": [ { "name": "Candesartan with CBT", "type": "DRUG" }, { "name": "Placebo with CBT", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 30, "start_date": "2013-01", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2019-09-04", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01938664" }, { "nct_id": "NCT01303783", "title": "Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension, Essential" ], "interventions": [ { "name": "Candesartan cilexetil (Atacand), 4 mg", "type": "DRUG" }, { "name": "Candesartan cilexetil (Atacand), 8 mg", "type": "DRUG" }, { "name": "Nifedipine GITS (Adalat, BAYA1040), 20 mg", "type": "DRUG" }, { "name": "Nifedipine GITS (Adalat, BAYA1040), 30 mg", "type": "DRUG" }, { "name": "Nifedipine GITS (Adalat, BAYA1040), 60 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Candesartan cilexetil (Atacand), 16 mg", "type": "DRUG" }, { "name": "Candesartan cilexetil (Atacand), 32 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1381, "start_date": "2011-04", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 23, "location_summary": "Mobile, Alabama • Los Angeles, California • Coral Gables, Florida + 18 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Deerfield Beach", "state": "Florida" }, { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01303783" }, { "nct_id": "NCT00320970", "title": "Angiotensin II Antagonism of TGF-Beta 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Nephropathy", "Hypertension" ], "interventions": [ { "name": "Candesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Providence Health & Services", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2002-08", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2007-08-02", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Spokane, Washington", "locations": [ { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00320970" }, { "nct_id": "NCT02646982", "title": "Candesartan's Effects on Alzheimer's Disease And Related Biomarkers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Cognitive Impairment" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Candesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 77, "start_date": "2016-06-30", "completion_date": "2020-08-17", "has_results": true, "last_update_posted_date": "2022-12-01", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02646982" }, { "nct_id": "NCT04430959", "title": "Candesartan as an Adjunctive Treatment for Bipolar Depression", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Bipolar Disorder Depression" ], "interventions": [ { "name": "Candesartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2020-10-01", "completion_date": "2022-09-01", "has_results": false, "last_update_posted_date": "2022-04-27", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04430959" }, { "nct_id": "NCT07547878", "title": "Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes" ], "interventions": [ { "name": "Finerenone", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Lotensin", "type": "DRUG" }, { "name": "Capoten", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" }, { "name": "Monopril", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Univasc", "type": "DRUG" }, { "name": "Aceon", "type": "DRUG" }, { "name": "Accupril", "type": "DRUG" }, { "name": "Altace", "type": "DRUG" }, { "name": "Mavik", "type": "DRUG" }, { "name": "Edarbi", "type": "DRUG" }, { "name": "Atacand", "type": "DRUG" }, { "name": "Avapro", "type": "DRUG" }, { "name": "Cozaar", "type": "DRUG" }, { "name": "Benicar", "type": "DRUG" }, { "name": "Micardis", "type": "DRUG" }, { "name": "Diovan", "type": "DRUG" }, { "name": "Invokana", "type": "DRUG" }, { "name": "Farxiga", "type": "DRUG" }, { "name": "Jardiance", "type": "DRUG" }, { "name": "Ertugliflozin", "type": "DRUG" }, { "name": "Brenzavvy", "type": "DRUG" }, { "name": "Sotagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 64, "start_date": "2026-04-30", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Temple, Texas", "locations": [ { "city": "Temple", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07547878" }, { "nct_id": "NCT01788358", "title": "Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 508, "start_date": "2013-02-14", "completion_date": "2014-05-01", "has_results": true, "last_update_posted_date": "2017-10-24", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 39, "location_summary": "Foley, Alabama • Carmichael, California • Los Angeles, California + 33 more", "locations": [ { "city": "Foley", "state": "Alabama" }, { "city": "Carmichael", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Milford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01788358" }, { "nct_id": "NCT01794455", "title": "Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression", "Hypertension" ], "interventions": [ { "name": "Sertraline", "type": "DRUG" }, { "name": "Candesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 1, "start_date": "2013-05", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2016-10-20", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01794455" }, { "nct_id": "NCT00005520", "title": "Genetic Epidemiology of Responses to Antihypertensives", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Heart Diseases", "Hypertension" ], "interventions": [ { "name": "Hydrochlorothiazide", "type": "DRUG" }, { "name": "Candesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 1200, "start_date": "1997-02", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2013-01-17", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005520" }, { "nct_id": "NCT03640312", "title": "Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "QUARTET LDQT", "type": "DRUG" }, { "name": "Candesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2019-08-30", "completion_date": "2024-07-31", "has_results": true, "last_update_posted_date": "2025-01-03", "last_synced_at": "2026-09-11T09:42:36.272Z", "location_count": 2, "location_summary": "Bloomingdale, Illinois • Chicago, Illinois", "locations": [ { "city": "Bloomingdale", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03640312" } ] }